Bazarbachi, A., & Dreger, P. (2018). Brentuximab vedotin prior to allogeneic stem cell transplantation in Hodgkin lymphoma: A report from the EBMT Lymphoma Working Party. British journal of haematology, 181(1), . https://doi.org/10.1111/bjh.15152
Chicago-Zitierstil (17. Ausg.)Bazarbachi, Ali, und Peter Dreger. "Brentuximab Vedotin Prior to Allogeneic Stem Cell Transplantation in Hodgkin Lymphoma: A Report from the EBMT Lymphoma Working Party." British Journal of Haematology 181, no. 1 (2018). https://doi.org/10.1111/bjh.15152.
MLA-Zitierstil (9. Ausg.)Bazarbachi, Ali, und Peter Dreger. "Brentuximab Vedotin Prior to Allogeneic Stem Cell Transplantation in Hodgkin Lymphoma: A Report from the EBMT Lymphoma Working Party." British Journal of Haematology, vol. 181, no. 1, 2018, https://doi.org/10.1111/bjh.15152.